Maternal barbiturate utilization and neonatal withdrawal symptomatology.
D000927:Anticonvulsants / Q000009:adverse effects; D001034:Apgar Score; D001463:Barbiturates; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D005865:Gestational Age; D003932:Heroin; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology* / Q000628:therapy; D008431:Maternal-Fetal Exchange; D010634:Phenobarbital / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D019966:Substance-Related Disorders; D013997:Time Factors
D000927:Anticonvulsants; D001463:Barbiturates; D003932:Heroin; D010634:Phenobarbital